Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Weighted Avg Shares
Average number of basic shares outstanding during the period, used to calculate basic EPS.
Weighted Avg Shares history
Shares · from the income statement
No Weighted Avg Shares data reported for this period type.
Weighted Avg Shares vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | 306.42M | +8.4% | +5.9% | |
| LTM Jun 2026 | 214.47M | +18.7% | +20.2% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | 142.11M | +51.7% | +47.9% |
| LTM Mar 2026 | 90.18M | +5.3% | +5.2% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — |
| Peer median (excluding AVLN) | 178.29M | +13.5% | +13.1% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.